Numerous updates in the glaucoma treatment landscape have had a big impact on patient outcomes. The introduction of minimally invasive glaucoma surgeries (MIGS) and the approval of new drugs with new mechanisms of action, for the first time in decades, have transformed the landscape. Ongoing research into new drug delivery systems is likely to provide more effective and convenient treatments in the future.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
A recent study published in the British Journal of Ophthalmology found that the location, size and volume of visual field (VF) defect clusters on an initial test can help predict which defects are likely to recur on future tests, aiding earlier and more reliable identification of glaucomatous damage.
Dr Syed Shoeb Ahmad is a leading glaucoma specialist and practising ophthalmologist based in India. A well-published expert in the field, he is also the creator of 'Glaucoma Specialist Blog: The Glog', an online resource designed to support ophthalmologists at all levels. In this Q&A, he shares his insights on the challenges of early diagnosis, advances in treatment, and the often-overlooked connection between glaucoma and systemic disease.
Encouraging results have emerged from two phase II clinical trials investigating a novel treatment, PER-001, for glaucoma and diabetic retinopathy, two of the most common causes of blindness globally. Delivered via a sustained-release intravitreal implant every six months, PER-001 improved both vision and retinal structure compared with control groups.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
We are delighted to share the latest issue of touchREVIEWS in Ophthalmology, showcasing a diverse range of articles that highlight the innovation, interdisciplinary collaboration and continued advances driving progress in eye care today. We begin this issue with an important ...
Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Breast carcinoma is the most common cancer in females. An estimated 2.3 million new cases of breast carcinoma are diagnosed annually worldwide.1Â These patients have potential risks of ocular complications not only from the secondaries in the eye but also due ...
This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.
The World Glaucoma Association (WGA) is thrilled to announce the 11th World Glaucoma Congress, scheduled for June 25-28, 2025, in Honolulu, Hawaii, USA. Held biennially, the WGC is the largest international meeting dedicated to glaucoma, providing a platform for young researchers to present their work and gain recognition within the global glaucoma community.
Three experts describe the pathophysiology and treatment options for open-angle glaucoma.
Contrast sensitivity (CS), which is an important element of functional vision, helps in differentiating an object from its background. CS affects several aspects of vision, such as acuity, dark adaptation, visual field, motion detection and pattern recognition.1 A decline in ...
The accumulation of transudative fluid in the suprachoroidal space, known as choroidal effusion, is a prevalent and often asymptomatic complication of glaucoma surgery. Choroidal effusions have also been linked with other aetiologies, including infections, inflammatory diseases, medications and other ocular ...
The challenge of patient adherence Patient adherence is a major concern in the field of glaucoma, where medication adherence rates can be as low as 40–55% due to complex dosing regimens, unpleasant side effects and difficulty with eyedrop administration.1,2 Moreover, 25% of ...
Glaucoma is a major cause of irreversible blindness worldwide.1,2Â High intraocular pressure (IOP) is one of the major risk factors for the development and progression of open-angle glaucoma (OAG) but is not an essential criterion for diagnosis.3,4Â Nonetheless, lowering the ...
Endothelial cell safety is an important factor to consider when selecting early surgical treatment for glaucoma patients. It was a pleasure to speak with Dr Ticiana De Francesco (Hospital de Olhos Leiria de Andrade (HOLA) Fortaleza, Brazil) around her study ...
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.